Conclusions: The findings of this study provided information regarding the medical direct costs for inpatient treatment of Thalassemia in the past three years along with the most appropriate model to forecast the medical direct cost per inpatient case in the future, from the Vietnam Social Health Insurance perspective. These evidence-based results can help healthcare managers and policymakers formulate and improve health policies to achieve universal health coverage in Vietnam.